Dopamine receptors and brain function

Neuropharmacology

Volumn 35, Issue 11, 1996, Pages 1503-1519

  Jaber, Mohamed ^a   Robinson, Susan W ^a   Missale, Cristina ^a   Caron, Marc G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Basal ganglia; Dopamine receptors; Gene expression; Neuroleptics; Pituitary; Schizophrenia; Signal transduction

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; APOMORPHINE; BROMOCRIPTINE; CLOZAPINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR AFFECTING AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; DYNORPHIN; FENOLDOPAM; GUANINE NUCLEOTIDE BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; NEUROLEPTIC AGENT; POSTSYNAPTIC RECEPTOR; PREPROENKEPHALIN; PRESYNAPTIC RECEPTOR; PROLACTIN; RECEPTOR SUBTYPE; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; SUBSTANCE P; SULPIRIDE; UNINDEXED DRUG;

AFFECT; BASAL GANGLION; BRAIN FUNCTION; COGNITION; DOPAMINERGIC TRANSMISSION; EXTRAPYRAMIDAL SYMPTOM; GENE EXPRESSION; HUMAN; HYPOPHYSIS; IMMEDIATE EARLY GENE; LOCOMOTION; MENTAL DISEASE; MOLECULAR BIOLOGY; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

ANIMALS; BRAIN; HUMANS; RECEPTORS, DOPAMINE;

EID: 0030458318     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(96)00100-1     Document Type: Review

References (189)

1. 2 dopamine receptor localization on striatonigral neurons. Neurosci. Lett. 144: 215-220.
2. Baertschi A. J., Audigier Y., Lledo P.-M., Israel J.-M., Bockaert J. and Vincent J.-D. (1992) Dialysis of lactotropes with antisense oligonucleotides assigns guanine nucleotide binding protein subtypes to their channel effectors. Molec. Endocrinol. 6: 2257-2265.
3. Baik J.-H., Picetti R., Salardi A., Thiriet G., Dietrich A., Depaulls A., Le Meur M. and Borrelli E. (1995) Parkinsonian-like locomotor impairement in mice lacking dopamine D2 receptors. Nature 377: 424-428.
4. Bergson C., Mrzljak L., Smiley J. F., Pappy M., Levenson R. and Goldman-Rakic P. S. (1995) Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain. J. Neurosci. 15: 7821-7836.
5. Bernard V., Le Moine C. and Bloch B. (1991) Striatal neurons express increased level of dopamine D2 receptor mRNA in response to haloperidol treatment: a quantitative in situ hybridization study. Neuroscience 45: 117-126.
6. Bethea C. L., Ramsdell J. F., Jaffe R. B., Wilson C. and Weiner R. I. (1982) Characterization of the dopaminergic regulation of human prolactin-secreting cells cultured on extracellular matrix. J. Clin. Endocrinol. Metab. 54: 893-902.
7. Bouthenet M. L., Souil E., Martres M. P., Sokoloff P., Giros B. and Schwartz J. C. (1991) Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. Brain Res. 564: 203-219.
8. Brené S., Lindefors N., Herrera-Marschitz M. and Persson H. (1990) Expression of dopamine D2 receptor and choline acetyltransferase mRNA in the dopamine deafferented rat caudate-putamen. Exp. Brain Res. 83: 96-104.
9. Brown J. H. and Makman M. H. (1972) Stimulation by dopamine of adenylate cyclase in retinal homogenates and of adenosine-3′ :5′-cyclic monophosphate formation in intact retina. Proc. Natn. Acad. Sci. U.S.A. 69: 539-543.
10. Buckland P. R., O'Donovan M. C. and McGuffin P. (1992) Changes in dopamine D1, D2 and D3 receptor mRNA levels in the rat brain following antipsychotic treatment. Psychopharmacology 106: 479-483.
11. Bunzow J. R., Van Tol H. H. M., Grandy D. K., Albert P., Salon A., Christie M. D., Machida C. A., Neve K. A. and Civelli O. (1988) Cloning and expression of a rat D2 dopamine receptor cDNA. Nature 336: 783-787.
12. Cadet J. L., Zhu S. M. and Angulo J. A. (1992) Quantitative in situ hybridization evidence for differential regulation of proenkephalin and dopamine D2 receptor mRNA levels in the rat striatum: effects of unilateral intrastriatal injections of 6-hydroxydopamine. Molec. Brain Res. 12: 59-67.
13. Canonico P. L., Valdenegro C. A. and MacLeod R. M. (1983) The inhibition of phosphatidylinositol turnover: a possible post receptor mechanism for the prolactin secretion-inhibiting effect of dopamine. Endocrinology 113: 7-14.
14. Caron M. G., Beaulieu M., Raymond V., Gange B., Drouin J., Lefkowitz R. J. and Labrie F. (1978) Dopaminergic receptors in the anterior pituitary gland. J. Biol. Chem. 253: 2244-2253.
15. Caron M. G., Hnatowitch M., Dohlman H., Bouvier M., Benovic J. L., O'Dowd B. F., Kobilka B. K., Hausdorff W. P. and Lefkowitz R. J. (1990) Structure and function of adrenergic receptors: models for understanding G protein-coupled receptors. In: G Proteins, (Eds. R. Iyengan and L. Binnbaumer) pp. 295-316. Academic Press, Orlando, Florida.
16. Carpenter W. T. Jr., Heinrichs D. W. and Alphs L. D. (1985) Treatment of negative symptoms. Schizophrenia Bull. 11: 440-452.
17. Carter-Russel H. R., Song W.-J. and Surmeier D. J. (1995) Coordinated expression of dopamine receptors (D1-D5) in single neostriatal neurons. Soc. Neurosci. Abstr. 559.11.
18. 2 short dopamine receptors inhibit voltage-dependent potassium current in neuroblastoma x glioma hybrid (NG108-15) cells. Molec. Pharmacol. 44: 649-656.
19. Castelletti L., Memo M., Missale C., Spano P. F. and Valerio A. (1989) Potassium channels involved in the transduction mechanism of dopamine D-2 receptors in rat lactotrophs. J. Physiol. (Lond.) 410: 251-265.
20. Chang S. L., Squinto S. P. and Harlan R. E. (1988) Morphine activation of c-fos expression in rat brain. Biochem. Biophys. Res. Commun. 2: 698-704.
21. Chen C.-L. C., Dionne F. T. and Roberts J. L. (1983) Regulation of the pro-opiomelanocortin mRNA levels in rat pituitary by dopaminergic compounds. Proc. Natn. Acad. Sci. U.S.A. 80: 2211-2215.
22. Chio C. L., Hess G. F., Graham R. S. and Huff R. M. (1990) A second molecular form of D2 dopamine receptor in rat and bovine caudate nucleus. Nature 343: 266-269.
23. 4 dopamine receptor-mediated signaling events determined in transfected Chinese hamster ovary cells. J. Biol. Chem. 269: 11813-11819.
24. 2 dopamine receptors. Molec. Pharmacol. 45: 51-60.
25. Civelli O., Bunzow J. R., Grandy D. K., Zhou Q.-Y. and Van Tol H. H. M. (1991) Molecular biology of the dopamine receptors. Eur. J. Pharmacol. 207: 277-286.
26. Clark D. and White F. J. (1987) D1 dopamine receptor - the search for a function. Synapse 1: 347-388.
27. 4 receptors coupled to adenylate cyclase. Proc. Natn. Acad. Sci. U.S.A. 89: 12093-12097.
28. Cools A. R. and Van Rossum J. M. (1976) Excitation mediating and inhibition mediating dopamine receptors: a new concept towards a better understanding of electrophysiological, biochemical, pharmacological, functional and clinical data. Psychopharmacologia 45: 243-254.
29. Coon H., Byerley W., Holik J., Hoff M., Myles-Worsley M., Lannfelt L., Sokoloff P., Schwartz J. C., Waldo M. and Freedman R. (1993) Linkage analysis of schizophrenia with five dopamine receptor genes in nine pedigrees. Am. J. Hum. Genet. 52: 327-334.
30. Cote T. E., Eskay R. L., Frey E. A., Grewe C. W., Munemura M., Stoof J. C., Tsuruta K. and Kebabian J. W. (1982) Biochemical and physiological studies of the b-adrenoreceptor and the D2 dopamine receptor in the intermediate lobe of the rat pituitary gland: a review. Neuroendocrinology 35: 217-224.
31. Creese I., Burt D. R. and Snyder S. H. (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192: 481-483.
32. 3H]-Spiperone labels dopamine receptors in pituitary and brain. Eur. J. Pharmacol. 46: 377-381.
33. Curran E. J. and Watson S. J. Jr. (1995) Dopamine receptor mRNA expression patterns by opioid peptide cells in the nucleus accumbens of the rat: a double in situ hybridization study. J. Comp. Neurol. 361: 57-76.
34. Dal Toso R., Sommer B., Ewart M., Herb A., Pritchett D. B., Bach A., Shivers B. D. and Seeburg P. H. (1989) The dopamine receptor: two molecular forms generated by alternative splicing. EMBO J. 8: 4025-4034.
35. Dearry A., Gingrich J. A., Falardeau P., Fremeau R. T., Bates M. D. and Caron M. G. (1990) Molecular cloning and expression of the gene for a human D1 dopamine receptor. Nature 347: 72-76.
36. 1-like receptors from Gallus domesticus. J. Biol. Chem. 270: 4005-4012.
37. Deutch A. Y., Moghaddam B., Innis R. B., Krystal J. H., Aghajanian G. K., Bunney B. S. and Charney D. S. (1991) Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia. Schizophrenia Res. 4: 121-156.
38. Diaz J., Levesque D., Griffon N., Lammers C. H., Martres M. P., Sokoloff P. and Schwartz J. C. (1994) Opposing roles for dopamine D2 and D3 receptors on neurotensin mRNA expression in nucleus accumbens. Eur. J. Neurosci. 6: 1384-1387.
39. Diaz J., Levesque D., Lammers C. H., Griffon N., Martres M. P., Schwartz J. C. and Sokoloff P. (1995) Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain. Neuroscience 65: 731-745.
40. Drago J., Gerfen C. R., Lachowicz J. E., Steiner H., Hollon T. R., Love P. E., Ooi G. T., Grinberg A., Lee E. J., Hunag S. P., Bartlett P. F., Jose P. A., Sibley D. R. and Westphal H. (1994) Altered striatal function in a mutant mouse lacking D1a dopamine receptors. Proc. Natn. Acad. Sci. U.S.A. 91: 12564-12568.
41. Dreher J. K. and Jackson D. M. (1988) Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats. Brain Res. 487: 267-277.
42. 2 dopamine receptor activation of potassium channels in identified rat lactotrophs: whole-cell and single-channel recording. J. Neurosci. 11: 3727-3737.
43. Elsholtz H. P., Lew A. M., Albert P. R. and Sundmark V. C. (1991) Inhibitory control of prolactin and Pit-1 gene promoters by dopamine. Dual signaling pathways required for D2 receptor regulated expression of the prolactin gene. J. Biol. Chem. 266: 22919-22925.
44. Enjalbert A. and Bockaert J. (3983) Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary. Molec. Pharmacol. 53: 576-584.
45. Enjalbert A., Sladeczek F., Guillon G., Bertrand P., Shu C., Epelbaum J., Garcia-Sainz A., Jard S., Lombard C., Kordon C. and Bockaert J. (1986) Angiotensin II and dopamine modulate both cAMP and inositol phosphate production in anterior pituitary cells. J. Biol. Chem. 261: 4071-4075.
46. Enjalbert A., Guillon G., Mouillac B., Audinot V., Rosolonjanahary R., Kordon C. and Bockaert J. (1990) Dual mechanisms of inhibition by dopamine of basal and thyrotropin-releasing hormone-stimulated inositol phosphate production in anterior pituitary cells. J. Biol.Chem. 265: 18816-18822.
47. i that amplifies ATP-mediated arachidonic acid release. Proc. Natn. Acad. Sci. U.S.A. 88: 6477-6480.
48. 1 dopamine agonists. Am. J. Physiol. 264: F1032-F1037.
49. Fishburn C. S., Belleli D., David C., Carmon S. and Fuchs S. (1993) A novel short isoform of the D3 dopamine receptor generated by alternative splicing in the third cytoplasmic loop. J. Biol. Chem. 268: 5872-5878.
50. Florio T., Pan M.-G., Newman B., Hershberger R. E., Civelli O. and Stork P. J. S. (1992) Dopaminergic inhibition of DNA synthesis in pituitary tumor cells is associated with phosphotyrosine phosphatase activity. J. Biol. Chem. 267: 24169-24172.
51. 1 receptor from goldfish retina: stimulation of cyclic AMP production and calcium mobilization. Molec. Pharmacol. 44: 1113-1118.
52. 3 dopamine receptor. J. Pharmacol. Exp. Ther. 268: 417-426.
53. 1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission. Proc. Natn. Acad. Sci. U.S.A. 88: 3772-3776.
54. Ganz M. B., Pachter J. A. and Barber D. L. (1990) Multiple receptors coupled to adenylate cyclase regulate Na-H exchange independent of cAMP. J. Biol. Chem. 265: 8989-8992.
55. Gerfen C. R. (1992) The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci. 15: 133-138.
56. Gerfen C. R., EngberT. M., Mahan L. C., Susel Z., Chase T. N., Mosma F. J. Jr. and Sibley D. R. (1990) D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250: 1429-1432.
57. Gerlach J., Behnke K., Heltberg J., Munk-Anderson E. and Nielson H. (1985) Sulpiride and haloperidol in schizophrenia: a double-blind cross-over study of therapeutic effects, side effects and plasma concentrations. Br. J. Psychiat. 147: 283-288.
58. Geyer M. A., Puerto A., Menkes D. B., Segal D. S. and Mandell A. J. (1976) Behavioral studies following lesions of the mesolimbic and mesostriatal serotonergic pathways. Brain Res. 106: 257-270.
59. Giannattasio G., De Ferrari M. E. and Spada A. (1981) Dopamine-inhibited adenylate cyclase in female rat adenohypophysis. Life Sci. 28: 1605-1612.
60. Gingrich J. A. and Caron M. G. (1993) Recent advances in the molecular biology of dopamine receptors. A. Rev. Neurosci. 16: 299-321.
61. Giros B. and Caron M. G. (1993) Molecular characterization of the dopamine transporter. Trends Pharmacol. Sci. 14: 43-49.
62. Giros B., Sokoloff P., Martres M. P., Riou J. F., Emorine L. J. and Schwartz J. C. (1989) Alternative splicing directs the expression of two D2 dopamine receptor isoforms. Nature 342: 923-926.
63. Giros B., Martres M. P., Pilon C., Sokoloff P. and Schwartz J. C. (1991) Shorter variants of the D3 dopamine receptor produced through various patterns of alternative splicing. Biochem. Biophys. Res. Commun. 176: 1584-1592.
64. Giros B., Jaber M., Jones S. R., Wightman R. M. and Caron M. G. (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 379: 606-612.
65. Grandy D. K., Zhang Y., Bouvier C., Zhou Q. Y., Johnson R. A., Allen L., Buck K., Bunzow J. R., Salon J. and Civelli O. (1991) Multiple human D5 dopamine receptor genes: a functional receptor and two pseudogenes. Proc. Natn. Acad. Sci. U.S.A. 88: 9175-9179.
66. Graybiel A. M., Moratalla R. and Robertson H. A. (1990) Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc. Natn. Acad. Sci. U.S.A. 87: 6912-6916.
67. Gusella J. H. (1989) Location cloning strategy for characterizing genetic defects in Huntington's disease and Alzheimer disease. FASEB J. 3: 2036-2041.
68. 2B subtypes in a heterologous cell line. Molec. Endocrinol. 6: 920-926.
69. Hersch S. M., Ciliax B. J., Gutekunst C. A., Rees H. D., Heilman C. J., Yung K. K., Bolam J. P., Ince E., Yi H. and Levev A. I. (1995) Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents. J. Neurosci. 15: 5222-5237.
70. Ingraham H. A., Chen R. P., Mangalan H. J., Elsholtz H. P., Flynn S. E., Lin C. R., Simmons D. M., Swanson L. and Rosenfeld M. G. (1988) A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype. Cell 55: 519-529.
71. Ingraham H. A., Albert V. R. and Chen R. (1990) A family of POU-domain and Pit-1 tissue-specific transcription factors in pituitary and neuroendocrine development. A. Rev. Physiol. 52: 773-791.
72. Israel J. M., Kirk C. and Vincent J. D. (1987) Electrophysiological responses to dopamine of rat hypophysial cells in lactotroph-enriched primary cultures. J. Physiol. 390: 1-22.
73. Jaber M., Fournier M. C. and Bloch B. (1992) Reserpine treatment stimulates enkephalin and D2 dopamine receptor gene expression in the rat striatum. Molec. Brain Res. 15: 189-194.
74. Jaber M., Tison F., Fournier M. C. and Bloch B. (1994) Differential influence of haloperidol and sulpiride on dopamine receptors and peptide mRNA levels in the rat striatum and pituitary. Molec. Brain Res. 23: 14-20.
75. Jaber M., Normand E. and Bloch B. (1995a) Effect of reserpine treatment on the preproenkephalin mRNA level in the rat striatum: an in situ hybridization study. Molec. Brain Res. 32: 156-160.
76. Jaber M., Cadore M., Dumartin B., Normand E., Stinus L. and Bloch B. (1995b) Acute and chronic amphetamine treatments differently regulate neuropeptide mRNA levels and Fos immunoreactivity in rat striatal neurons. Neuroscience 65: 1041-1050.
77. Jackson D. M. and Westlind-Danielson A. (1994) Dopamine receptors: molecular biology, biochemistry and behavioral aspects. Pharmacol. Ther. 64: 291-369.
78. Kane J. M. and Freeman H. L. (1994) Towards more effective antipsychotic treatment. Br. J. Psychiat. 165: 22-31.
79. 2 dopamine receptors mediate the potentiation of arachidonic acid release in Chinese hamster ovary cells. Molec. Pharmacol. 39: 364-369.
80. Kebabian J. W. and Calne D. B. (1979) Multiple receptors for dopamine. Mature 277: 93-96.
81. Kebabian J. W., Petzold G. L. and Greengard P. (1972) Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain and its similarity to the "dopamine receptor". Proc. natn. Acad. Sci. U.S.A. 69: 2145-2149.
82. 1 rat somatomammotrophic cells. J. Neurochem. 64: 21 18-2124.
83. o. J. Biol. Chem. 270: 14672-14678.
84. Kohler C. and Fahlberg K. (1985) Specific in vivo binding of 3H-spiperone to individual lobes of the pituitary gland of the rat. Evidence tor the labeling of dopamine receptors. J. Neural. Trans. 63: 39-52.
85. Kukstas E. A., Domec C., Bascles E., Bonnet J., Venier D., Israel J. M. and Vincent J. D. (1991) Different expression of the two dopaminergic D2 receptors, D2415 and D2444, in two types of lactotroph each characterized by their response to dopamine and modification of expression by sex steroids. Endocrinology 129: 1101-1103.
86. LaHoste G. J., Yu J. and Marshall J. F. (1993) Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity. Proc. natn. Acad. Sci. U.S.A. 90: 7451-7455.
87. 1 receptors independently of adenylyl cyclase activation. J. Neurochem. 61: 1461-1469.
88. 2 dopamine receptor stimulation of mitogenesis in transfected Chinese hamster ovary cells: relationship to dopamine stimulation of tyrosine phosphorylations. J. Pharmacol. Exp. Ther. 267: 1573-1581.
89. Le Moine C. and Bloch B. (1995) D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J. Comp. Neurol 355: 418-426.
90. Le Moine C. and Bloch B. (1996) Expression of the D3 dopamine receptor in peptidergic neurons of the nucleus accumbens: comparison with the D1 and D2 dopamine receptors. Neuroscience. 73: 131-143.
91. Le Moine C., Normand E., Guitteny A. F., Fouque B., Teoule R. and Bloch B. (1990) Dopamine receptor gene expression by enkephalin neurons in rat forebrain. Proc. Natn. Acad. Sci. U.S.A. 87: 230-234.
92. Le Moine C., Normand E. and Bloch B. (1991) Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene. Proc. Natn. Acad. Sci. U.S.A. 88: 4205-4209.
93. Lefkowitz R. J. and Caron M. G. (1988) The adrenergic receptors: models for the study of receptors coupled to guanine nucleotide regulatory proteins. J. Biol. Chem. 263: 4993-4996.
94. Lester J., Fink J. S., Aronin N. and DiFiglia M. (1993) Colocalization of D1 and D2 dopamine receptor messenger RNAs in striatal neurons. Brain Res. 621: 106-110.
95. Lew A. M. and Elsholtz H. P. (1995) A dopamine-responsive domain in the N-terminal sequence of Pit-1. J. Biol. Chem. 270: 7156-7160.
96. 3H]spiperone binding sites in the intermediate lobe of the rat pituitary gland. Neurosci. Lett. 32: 99-102.
97. 1 receptor: selective potentiation by protein kinase A. Molec. Endocrinol. 6: 1815-1824.
98. 2 receptor subtypes to protein kinase C. J. Nerurochem. 59: 2311-2317.
99. 1 pituitary cells. J. Biol. Chem. 269: 13880-13886.
100. Lledo P. M., Legenohe P., Zhang J., Israel J. M. and Vincent J. D. (1990a) Effects of dopamine on voltage-dependent potassium currents in identified rat lactotroph cells. Neuroendocrinology 52: 545-555.
101. Lledo P. M., Legenohe P., Israel J. M. and Vincent J. D. (1990b) Dopamine inhibits two characterized voltage-dependent calcium currents in identified rat lactotroph cells. Endocrinology 127: 990-1001.
102. 2+ currents in rat anterior pituitary cells. Neuron 8: 455-463.
103. 4 dopamine receptor gene variant in an Italian Schizophrenia kindred. Arch. Gen. Psychiat. 51: 288-293.
104. 3 receptor expressed in transfected cell lines. Eur. J. Pharmacol. 266: 79-85.
105. ++ increases in rat lactotroph cells. J. Biol. Chem. 262: 13920-13927.
106. 2 receptor. Eur. J. Pharmacol. 227: 205-214.
107. Martres M. P., Sokoloff P., Giros B. and Schwartz J. C. (1992) Effects of dopaminergic transmission interruption on the D2 receptor isoforms in various cerebral tissues. J. Neurochem. 58: 673-679.
108. Matthysse S. (1974) Dopamine and the pharmacology of schizophrenia: the state of the evidence. J. Psychiat. Res. 11: 107-113.
109. 4 dopamine receptors in HEK293 cells. J. Recept. Signal Trans. Res. 15: 267-281.
110. McDonald W. M., Sihley D. R., Kilpatrick B. F. and Caron M. G. (1984) Dopaminergic inhibition of adenylate cyclase correlates with high affinity agonist binding to anterior pituitary D2 dopamine receptors. Molec. Cell Endrocrinol. 36: 201-209.
111. Meador-Woodruff J. H., Mansour A., Bunzow J. R., Van Tol H. H. M., Watson S. J. and Civelli O. (1989) Distribution of D2 dopamine receptor mRNA in rat brain. Proc. Natn. Acad. Sci. U.S.A. 86: 7625-7628.
112. Meador-Woodruff J. H., Mansour A., Grandy D. K., Damask S. P., Civelli O. and Watson S. J. Jr. (1992) Distribution of D5 dopamine receptor mRNA in rat brain. Neurosci. Lett. 145: 209-212.
113. Meltzer H. Y. (1989) Clinical studies on the mechanism of action of clozapine: the dopamine-serotomn hypothesis of schizophrenia. Psychopharmacology 99: S18-S27.
114. Meltzer H. Y. (1991) The mechanism of action of novel antipsychotic drugs. Schizophrenia Bull. 17: 263-287.
115. Meltzer H. Y. (1992) Treatment of the neuroleptic-nonresponsive schizophrenia patient. Schizophrenia Bull. 18: 515-542.
116. Memo M., Castelletti L., Missale C., Valerio A., Carruba M. O. and Spano P. F. (1986) Dopaminergic inhibition of prolactin release and calcium influx induced by neurotensin in anterior pituitary is independent of cyclic AMP system. J. Neurochem. 47: 1689-1695.
117. Memo M., Pizzi M., Belloni M. Benarese M. and Spano P. F. (1992) Activation of dopamine D2 receptors linked to voltage-sensitive potassium channels reduces forskolin-induced cyclic AMP formation in rat pituitary cells. J. Neurochem. 59: 1829-1835.
118. 3 cells exposed to epidermal growth factor. J. Biol. Chem. 266: 23392-23398.
119. 2 dopamine receptor gene region and schizophrenia. Arch. Gen. Psychiat. 48: 643-647.
120. 2 dopamine receptors produced by alternative RNA splicing. Nature 342: 926-929.
121. 1 dopamine receptor linked to adenylyl cyclase activation. Proc. Natn. Acad. Sci. U.S.A. 87: 6723-6727.
122. 2 receptors. Proc. Natn. Acad. Sci. U.S.A. 88: 3135-3139.
123. 2 receptors and G-proteins. Molec. Endocrinol. 7: 161-170.
124. Munemura M., Cote T. E., Tsuruta K., Eskay R. L. and Kebabian J. W. (1980) The dopamine receptor in the intermediate lobe of the rat anterior pituitary gland: pharmacological characterization. Endocrinology 106: 1676-1683.
125. Nakajima T., Daval J.-L., Morgan P. F., Post R. M. and Maragos P. J. (1989) Adenosynergic modulation of caffeine-induced c-fos mRNA expression in mouse brain. Brain Res. 501: 307-314.
126. 3 receptor gene locus. Am. J. Med. Genet. 54: 264-267.
127. Nelson C., Albert R., Elsholtz H. P., Lu L. I. and Rosenfeld M. G. (1988) Activation of cell-specific expression of rat growth hormone and prolactin genes by a common transcription factor. Science 239: 1400-1405.
128. + exchange assessed by quantification of extracellular acidification. J. Biol. Chem. 267: 25748-25753.
129. Normand E., Popovici T., Fellmann D. and Bloch B. (1987) Anatomical study of enkephalin gene expression in the rat forebrain following haloperidol treatment. Neurosci. Lett. 83: 232-236.
130. Nussinovitch I. and Kleinhaus A. L. (1992) Dopamine inhibits voltage-activated calcium channel currents in rat pars intermedia pituitary cells. Brain Res. 574: 49-55.
131. 4 receptor: sequence, gene structure, and demonstration of expression in the cardiovascular system. The New Biologist 4: 137-146.
132. Onali P., Schwanz J. P. and Costa E. (1983) Inhibition of VIP-sensitive adenylate cyclase by dopamine in rat anterior pituitary. Adv. Biochem. Psychopharmacol. 36: 199-207.
133. 2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. J. Neurosci. 12: 3729-3742.
134. 1b receptor. Eur. J. Pharmacol. 267: 85-93.
135. 3 receptor in a transfected NG108-15 neuroblastoma-glioma hybrid cell line. Eur. J. Pharmacol. 268: 129-139.
136. 3 dopamine receptors. J. Neurosci. 14: 1463-1476.
137. 2 synergism. Nature 353: 164-167.
138. 5 dopamine receptor gene. Psychiat. Genet. 4: 77-80.
139. Reynolds G. P. (1989) Beyond the dopamine hypothesis. Br. J. Psychiat. 155: 305-316.
140. Robertson G. S. and Fibiger H. C. (1992) Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine. Neuroscience 46: 315-328.
141. Rohertson H. A. (1992a) Immediate-early genes, neuronal plasticity and memory. Biochem. Cell Biol. 70: 729-737.
142. Robertson H. A. (1992b) Dopamine receptor interactions: some implications for the treatment of Parkinson's disease. Trends Neurosci. 15: 201-206.
143. Rodrigues P. S. and Dowling J. E. (1990) Dopamine induces neurite retraction in retinal horizontal cells via diacylglycerol and protein kinase C. Proc. Natn. Acad. Sci. U.S.A. 87: 9693-9697.
144. 1, pituitary cells. FEBS Lett. 312: 123-126.
145. 3 dopamine receptors in differentiated neuroblastoma x glioma NG108-15 cells. Br. J. Pharmacol. 111: 391-393.
146. 2 (short) dopamine receptors expressed in differentiated NG108-15 cells. Br. J. Pharmacol. 111: 1061-1066.
147. 4 dopamine receptors. Bur. J. Pharmacol. 112: 728-734.
148. Seeman P. (1980) Brain dopamine receptors. Pharmacol. Rev. 32: 229-313.
149. 2 dopamine receptors. Clin. Neuropharmacol. 13: 124-125.
150. 4. Neuropsychopharmacology 7: 261-284.
151. Seeman P. and Van Tol H. H. M. (1994) Dopamine receptor pharmacology. Trends Neurosci. 15: 264-270.
152. 3H] nemonapride. J. Neurochem. 64: 1413-1415.
153. Seeman P., Chau-Wong M. and Wong K. (1975) Brain receptors for antipsychotic drugs and dopamine: direct binding assays. Proc. Natn. Acad. Sci. U.S.A. 72: 4376-4380.
154. 4 receptors elevated in schizophrenia. Nature 365: 441-445.
155. 7 cells: involvement of protein kinase-Ce. Endocrinology 134: 783-789.
156. Senogles S. E., Amlaiky N., Falardeau P. and Caron M. G. (1988) Purification and characterization of the D-2 dopamine receptor from bovine anterior pituitary. J. Biol. Chem. 263: 18996-19002.
157. Senogles S. E., Spiegel A. M., Padrell E., Iyengar R. and Caron M. G. (1990) Specificity of receptor-G protein interactions. J. Biol. Chem. 265: 4507-4514.
158. 1a dopamine receptor gene promoter directs expression of a receptor gene to the central nervous system in transgenic mice. Molec. Brain Res. 30: 336-346.
159. 4 receptor gene and schizophrenia. Am. J. Med. Gen. 54: 8-11.
160. Sigmundson H. K. (1994) Pharmacotherapy of schizophrenia: a review. Can. J. Psychiat. (Suppl.) 39: 70-75.
161. Simmonds S. H. and Strange P. G. (1985) Inhibition of inositolphospholipid breakdown by D-2 receptors in dissociated bovine anterior pituitary cells. Neurosci. Lett. 60: 267-272.
162. Sokoloff P. and Schwartz J. C. (1995) Novel dopamine receptors half a decade later. Trends Pharmacol. Sci. 16: 270-275.
163. 3) as a target for neuroleptics. Nature 347: 146-151.
164. Spano P. F., Govoni S. and Trabucchi M. (1978) Studies on the pharmacological properties of dopamine receptors in various areas of the central nervous system. Adv. Biochem. Psychopharmacol. 198: 155-165.
165. Stack J. and Surprenant A. (1991) Dopamine actions on calcium currents, potassium currents and hormone release in rat mehtnotrophs. J. Physiol. 493: 37-58.
166. 2 dopamine receptor gene region of chromosome 11q in 112 Irish mutiplex families. Arch. Gen. Psychiat. 50: 205-211.
167. 1C dopamine receptors from Xenopus laevis. Proc. Natn. Acad. Sci. U.S.A. 91: 10536-10540.
168. 1 receptor encoded by an intronless gene on chromosome 5. Nature 347: 81-83.
169. 1. Nature 350: 614-619.
170. Surmeier D. J., Eherwine J., Wilson C. J., Cao Y., Stefani A. and Kitai S. T. (1992) Dopamine receptor subtypes colocalize in rat striatonigral neurons. Proc. Natn. Acad. Sci. U.S.A. 89: 10178-10182.
171. 4 dopamine receptors revealed in transfected neuronal cell lines. Proc. Natn. Acad. Sci. U.S.A. 91: 649-653.
172. 4 dopamine receptors in fibroblast and dopaminergic cell lines. J. Pharmacol. Exp. Ther. 268: 495-502.
173. 3 receptors inhibit dopamine release. J. Pharmacol. Exp. Ther. 270: 475-479.
174. 1B receptor subtype. J. Biol. Chem. 269: 27925-27931.
175. Tiberi M., Jarvie K. R., Silvia C., Falardeau P., Gingrich J. A., Godinot N., Bertrand L., Yang-Feng T. L., Fremeau R. T. and Caron M. G. (1991) Cloning, molecular characterization, and chromosomal assignment of a gene encoding a second D1 dopamine receptor subtype: differential expression pattern in rat brain compared with the D1a receptor. Proc. Natn. Acad. Sci. U.S.A. 88: 7491-7495.
176. 1 receptor mutagenesis: role of amino acids in agonist and antagonist binding. Biochem. Biophys. Res. Communun. 191: 1020-1027.
177. 1 receptor enhances inositol phosphates formation in rat brain. J. Pharmacol. Exp. Ther. 253: 987-992.
178. 1 cells. J. Biol. Chem. 265: 10320-10326.
179. 4 receptor with high affinity for the antipsychotic clozapine. Nature 350: 610-614.
180. Van Tol H. H. M., Wu C. M., Guan H. C., Ohara K., Bunzow J. R., Civelli O., Kennedy J., Seeman P., Niznik H. B. and Jovanovic V. (1992) Multiple dopamine D4 receptor variants in the human population. Nature 358: 149-152.
181. Vernier P., Cardinaud B., Valdenaire O., Herve P. and Vincent J.-D. (1995) An evolutionary view of drug-receptor interaction: the bioamine receptor family. Trends Pharmacol. Sci. 16: 375-381.
182. Voss J. W. and Rosenfeld M. G. (1992) Anterior pituitary development: short tales from dwarf mice. Cell 70: 527-530.
183. Waddington J. L. (1989) Functional interactions between D1 and D2 dopamine receptor systems. J. Psychopharmacol. 3: 54-63.
184. Weiner D. M., Levey A. I., Sunahara R. K., Niznik H. H., O'Dowd B. F. and Brann M. R. (1991) Dopamine D1 and D2 receptor mRNA expression in rat brain. Proc. Natn. Acad. Sci. U.S.A. 88: 1859-1863.
185. Weinshank R. L., Adham N., Macchi M. Olsen M. A., Branchek T. A. and Hartig P. R. (1991) Molecular cloning and characterization of a high affinity dopamine receptor (D1 beta) and its pseudogene. J. Biol. Chem. 266: 22427-22435.
186. Xu M., Moratalla R., Gold L. H., Hiroi N., Koob G. F., Graybiel A. M. and Tonegawa S. (1994a) Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell 79: 729-742.
187. Xu M., Hu X.-T., Cooper D. C., Moratalla R., Graybiel A. M., White F. J. and Tonegawa S. (1994b) Elimination of cocaine-mediated neurophysiological effects in Dopamine D1 receptor mutant mice. Cell 79: 945-955.
188. Yang-Feng T. L., Xue F. Y., Zhong W. W., Cotecchai S., Frielle T., Caron M. G., Lefkowitz R. J. and Francke U. (1990) Chromosomal organization of adrenergic receptor genes. Proc. Natn. Acad. Sci. U.S.A. 87: 1516-1520.
189. Zhou Q. Y., Grandy D. K., Thambi L., Kushner. J. A., Van Tol H. H. M., Cone R., Pribnow D., Salon J., Bunzow J. R. and Civelli O. (1990) Cloning and expression of human and rat D1 dopamine receptors. Nature 347: 76-80.